Profile data is unavailable for this security.
About the company
Nextgen Biomed Ltd is an Israel-based research and development company. Its main activity is to own EyePen product. The Company's product is dedicated to people with diabetes and consists of an injection module which allows to monitor the doses and time of insulin intake. The EyePen mobile app keeps diabetes management systematic by monitoring behavior and provides alerts for human errors such as forgetting a pen, double insulin injections, or skipping injections.
- Revenue in ILS (TTM)0.00
- Net income in ILS-9.00m
- Incorporated1990
- Employees187.00
- LocationNextgen Biomed LtdOppenheimer 7REHOVOT 7670107IsraelISR
- Phone+972 33742282
- Fax+972 98849441
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Erech Finance Cahalacha Ltd | 282.00k | -25.29m | 8.16m | 18.00 | -- | 1.88 | -- | 28.94 | -9.97 | -9.97 | 0.1112 | 1.71 | 0.0061 | -- | 0.019 | -- | -53.84 | -15.68 | -132.10 | -31.24 | -659.22 | 66.49 | -8,841.49 | -133.65 | -- | -11.04 | 0.7966 | -- | -97.35 | -50.83 | -1.01 | -- | -- | -- |
| Nextgen Biomed Ltd | 0.00 | -9.00m | 8.23m | 187.00 | -- | 0.7161 | -- | -- | -2.70 | -2.70 | 0.00 | 1.42 | 0.00 | -- | -- | -- | -51.61 | -32.00 | -54.98 | -35.24 | -- | -- | -- | -- | -- | -- | 0.1054 | -- | -- | -- | -236.16 | -- | -- | -- |
| Human Xtensions Ltd | 4.95m | -36.64m | 10.57m | 50.00 | -- | 0.4048 | -- | 2.14 | -1.37 | -1.37 | 0.185 | 0.9757 | 0.0922 | 0.4634 | 2.21 | 99,000.00 | -68.25 | -49.34 | -77.27 | -55.69 | 51.66 | 49.34 | -740.10 | -485.43 | 4.75 | -- | 0.0608 | -- | 56.00 | -- | 17.84 | -- | -19.95 | -- |
| Sonovia Ltd | 0.00 | -26.81m | 11.72m | 44.00 | -- | 0.3614 | -- | -- | -1.66 | -1.49 | 0.00 | 1.97 | 0.00 | -- | -- | 0.00 | -55.93 | -- | -62.66 | -- | -- | -- | -- | -- | -- | -13.62 | 0.0054 | -- | -- | -- | -187.75 | -- | 77.26 | -- |
| Elbit Medical Technologies Ltd | 1.28m | -65.53m | 17.86m | 232.00 | -- | 0.6718 | -- | 13.93 | -0.7302 | -0.7302 | 0.0146 | 0.293 | 0.0211 | -- | 38.67 | -- | -108.02 | 37.04 | -110.43 | 38.19 | -- | -- | -5,113.22 | 41.14 | -- | -0.011 | 0.00 | -- | 314.29 | -55.19 | -248.15 | -- | -- | -- |
| BioLight Life Sciences Ltd | 118.00k | -26.02m | 18.99m | 4.00 | -- | 0.6379 | -- | 160.97 | -5.60 | -5.60 | 0.0255 | 6.39 | 0.0026 | -- | 0.2903 | 29,500.00 | -60.77 | -20.22 | -65.01 | -21.13 | -- | -- | -23,294.07 | -12,746.09 | -- | -0.6326 | 0.003 | -- | 87.30 | -49.76 | -231.59 | -- | 92.16 | -- |
| Allmed Solutions Ltd | 0.00 | 1.42m | 33.16m | 19.00 | 18.93 | 0.6986 | 17.47 | -- | 0.0182 | 0.0182 | 0.00 | 0.4924 | 0.00 | -- | -- | 0.00 | 2.43 | 1.43 | 2.68 | 1.59 | -- | 50.43 | -- | 15.58 | -- | -- | 0.0154 | -- | -- | -- | 111.71 | -- | -10.48 | -- |
| Erika B-Cure Laser Ltd | 29.88m | -19.22m | 33.75m | -- | -- | 1.42 | -- | 1.13 | -0.185 | -0.185 | 0.2876 | 0.2278 | 0.5184 | 0.3945 | 4.08 | -- | -33.34 | -- | -49.63 | -- | 76.95 | 87.63 | -64.32 | -14.48 | 0.8936 | -- | 0.1726 | -- | -40.62 | -3.40 | 40.97 | -- | -19.27 | -- |
Data as of May 21 2024. Currency figures normalised to Nextgen Biomed Ltd's reporting currency: Israeli Shekel ILS
